Authors: van der Burg, SH Kwappenberg, KMC O'Neill, T Brandt, RMP Melief, CJM Hickling, JK Offringa, R

Citation: Sh. Van Der Burg et al., Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens, VACCINE, 19(27), 2001, pp. 3652-3660

Authors: van der Burg, SH Ressing, ME Kwappenberg, KMC de Jong, A Straathof, K de Jong, J Geluk, A van Meugaarden, KE Franken, KLMC Ottenhoff, THM Fleuren, GJ Kenter, G Melief, CJM Offringa, R

Citation: Sh. Van Der Burg et al., Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes, INT J CANC, 91(5), 2001, pp. 612-618

Authors: van der Burg, SH Kwappenberg, KMC Geluk, A van der Kruk, M Pontesilli, O Hovenkamp, E Franken, KLMC van Meijgaarden, KE Drijfhout, JW Ottenhoff, THM Melief, CJM Offringa, R

Citation: Sh. Van Der Burg et al., Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4(+) T cells by at least four unrelated HLA-DR molecules, J IMMUNOL, 162(1), 1999, pp. 152-160

Authors: Kammer, AR van der Burg, SH Grabscheid, B Hunziker, IP Kwappenberg, KMC Reichen, J Melief, CJM Cerny, A

Citation: Ar. Kammer et al., Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition, J EXP MED, 190(2), 1999, pp. 169-176